Predicting Intubation of Patients Hospitalised for Acutely Attacked Asthma

June 28, 2020 updated by: Narongwit Nakwan, Hat Yai Medical Education Center

Predicting Factors of Intubation in Hospitalised Patients With Acutely Attacked Asthma

Although the asthmatic treatments currently be effective in term of efficacy of inhaled medications and good clinical outcome including symptom controlled and asthma exacerbation number, the large number of worse event still have been reported. Few cases eventually have been intubated and died even though using optimal medication. In this study, we will search to identify factors that may influence intubation in hospitalised patient with asthmatic attack.

Study Overview

Status

Completed

Study Type

Observational

Enrollment (Actual)

509

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Songkhla
      • Hat Yai, Songkhla, Thailand, 90110
        • Hatyai Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

15 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Population in this study is a the patient who had been admitted with moderate to severe asthmatic attack. The study will be retrospective review with data in medical record between year 2016-2018. The baseline characteristic and factors which has a potential to intubation will be recored.

Description

Inclusion Criteria:

  • Patients who had been admitted and diagnosed as asthmatic attack between year 2016-2018.
  • Patients who have age > 15 year old.

Exclusion Criteria:

  • Non

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intubated asthma attack
Patients who had been hospitalised with asthma attack, then intubated during hospitalisation.
Non-Intubated asthma attack
Patients who had been hospitalised with asthma attack without intubation during hospitalisation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number case of intubated patient
Time Frame: Retropectively review 2 years backard between 2017-2018
Number case of hospitalized asthmatic attack patients during 2-year review.
Retropectively review 2 years backard between 2017-2018

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of previous asthma attack before this admission
Time Frame: 1 year before admission
Number of previous asthma attack with 12 months before this hospitalization.
1 year before admission
Blood eosinophil count at admission time
Time Frame: Retropectively review 2 years backard between 2017-2018
Blood eosinophil may help predict outcome and risk for intubation.
Retropectively review 2 years backard between 2017-2018
Number patients dead
Time Frame: Retropectively review 2 years backard between 2017-2018
Number patient dead during hospitalization
Retropectively review 2 years backard between 2017-2018

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Narongwit Nakwan, M.D., Hatyai Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2020

Primary Completion (Actual)

May 30, 2020

Study Completion (Actual)

May 30, 2020

Study Registration Dates

First Submitted

February 15, 2020

First Submitted That Met QC Criteria

February 18, 2020

First Posted (Actual)

February 20, 2020

Study Record Updates

Last Update Posted (Actual)

June 30, 2020

Last Update Submitted That Met QC Criteria

June 28, 2020

Last Verified

February 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Asthma

3
Subscribe